Join Ambry Genetics for exciting, on-demand updates in genetic technologies and clinical diagnostics. Ambry’s core values have always included collaborating and sharing scientific discoveries to help families affected by genetic conditions. Tune in here for cutting-edge discussions from leading clinicians, scientists, and researchers on a wide variety of topics.
http://www.blogtalkradio.com/ambrygenetics
PARP Inhibitors in Ovarian Cancer Treatment
In this webinar, Dr. Anne Kathryn Goodman provides an overview of ovarian cancer types, risk factors, and therapies. She describes the mechanism of PARP inhibitors and compares them to traditional ovarian cancer treatments.